Form: S-1

General form of registration statement for all companies including face-amount certificate companies

Documents

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-1

(Form Type)

 

BIOAFFINITY TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type		   Security
Class
Title		   Fee
Calculation
Rule		     Amount
Registered		     Proposed
Maximum
Offering
Price Per
Unit		     Maximum
Aggregate
Offering
Price (1)(2)		     Fee
Rate		     Amount of
Registration
Fee		  
Newly Registered Securities  
Fees to be paid   Equity   Units consisting of (i) one share of Common Stock, par value $0.007 per share, and (ii) one warrant to purchase one share of Common Stock(2)     457 (o)     —       —     $ 5,750,000     $ 0.00011020     $ 633.65  
Fees to be paid   Equity   Shares of Common Stock, included as part of the Units     457 (i)     —       —       —       —       —  
Fees to be paid   Equity   Warrants to purchase shares of Common Stock, included as part of the Units     457 (i)     —       —       —       —       —  
Fees to be paid   Equity   Shares of Common Stock issuable upon exercise of the Warrants included in the Units     457 (i)                   $ 6,900,000     $ 0.00011020     $ 760.38  
Fees to be paid   Equity   Representative’s Warrants(3)     457 (g)     —       —       —       —       —  
Fees to be paid   Equity   Shares of Common Stock issuable upon exercise of the Representative’s Warrants(4)     457 (g)     —       —     $ 138,000     $ 0.00011020     $ 15.21  
Total Offering Amounts             $ 12,788,000             $ 1,409.24  
Total Fees Previously Paid                               —  
Total Fee Offsets                               —  
Net Fee Due                             $ 1,409.24  

 

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there are also being registered such indeterminate number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends and similar transactions.
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.
(3) No separate registration fee required pursuant to Rule 457(g) of the Securities Act.
(4) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. We have agreed to issue to the representative of the underwriters warrants to purchase the number of shares of our common stock (the “Representative’s Warrants”) in the aggregate equal to two percent (2%) of the shares of our common stock to be issued and sold in this offering (including shares issuable upon exercise of the over-allotment option described herein). The Representative’s Warrants are exercisable for a price per share equal to 120% of the public offering price. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g), the proposed maximum aggregate offering price of the Representative’s Warrants is $138,000, which is equal to 120% of $115,000 (2% of $5,750,000).